
Business and People: July 2015
New faces among the Pharma Industry rise the ranks
People News
ROS NT LLC announced today they have appointed Mark Paul as Senior Vice President, US Operations. He will be responsible for the company’s U.S. operation and will represent U.S. interests on the global leadership team. Mr. Paul brings significant experience to the position having served in senior management roles at Quintiles, Health Decisions, StatWorks, and most recently Veracity Logic.
Andrew MacGarvey, CEO of CROS NT, said, “I am delighted to welcome Mark to our company. We are growing our customer base in the United States and increasing the size of our group here. Mark has great experience in delivering global projects and in growing and developing operational teams. He will oversee our continued growth in the region and will work closely with our customers to ensure they receive the highest levels of service”.
Ashfield has announced that Clint Burrus will take on the role of Senior Vice President, Business Development for Ashfield Market Access. In this role, Mr. Burrus will be responsible for identifying new business opportunities and ensuring the successful execution of key client projects.
ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, today announced the appointment of Steve Nuckols to the position of Executive Vice President and Chief Commercial Officer (CCO). As CCO, Nuckols will be responsible for all global business development activities within ERT, with primary focus on ensuring ERT’s products and services best meet the needs of its global pharmaceutical customers.
CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization announces the promotions of Dr. Günter Stetter and Sibylle Lawson. Dr. Günter Stetter has been promoted to Senior Director of Clinical Operations, Europe, where he is responsible for overseeing the clinical operations for all CTI European offices and work taking place throughout the continent. Sibylle Lawson has been promoted to Assistant Director, Clinical Trials, where she will continue to oversee global clinical studies across a variety of disease indications.
endpoint has promoted Chuck Harris to General Manager. Jonathan Dole, CEO and co-founder of endpoint stated: "We are extremely pleased to announce Chuck's promotion. In this role, Chuck will be responsible for the execution of endpoint's mission to deliver a highly customizable, fully configurable SaaS IRT offering to our global customer base." Chuck has provided quality and operations leadership in the IRT industry for more than 14 years, having most recently served as endpoint's director of product development.
Metrics Contract Services (Metrics) has added a new senior formulation scientist to its growing staff of pharmaceutical experts. Among his other duties, Michael R. Mascarenas is responsible for the formulation and process development of early-phase oral dosage forms, and oversees the manufacture of clinical trial materials to support client-sponsored research studies.
Business/Awards News
Schulman Associates IRB, Inc., a central IRB in customer service and technology, announces the acquisition of Missouri-based
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.